1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. AMGEN INC.
AMGEN Inc. XNAS: AMGN

AMGEN Inc. Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

Read More
295.27 -5.10 (-1.70%)
1.6M
XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
40.8 / 100
Momentum Score
Technically Neutral
56.4 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
314
1Yr Price target upside is 6%
28 analysts

4

S

12

W

2

O

2

T

SWOT Analysis

Amgen Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..